[1]
2025. Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287). SKIN The Journal of Cutaneous Medicine. 9, 4 (Jul. 2025), s588. DOI:https://doi.org/10.25251/yvdyat28.